Literature DB >> 28538165

The COMPLEXity in herpesvirus entry.

Karthik Sathiyamoorthy1, Jia Chen2, Richard Longnecker2, Theodore S Jardetzky3.   

Abstract

Enveloped viruses have evolved diverse transmembrane proteins and protein complexes to enable host cell entry by regulating and activating membrane fusion in a target cell-specific manner. In general terms, the entry process requires a receptor binding step, an activation step and a membrane fusion step, which can be encoded within a single viral protein or distributed among multiple viral proteins. HIV and influenza virus, for example, encode all of these functions in a single trimeric glycoprotein, HIV env or influenza virus hemagglutinin (HA). In contrast, herpesviruses have the host receptor binding, activation and fusogenic roles distributed among multiple envelope glycoproteins (ranging from three to six), which must coordinate their functions at the site of fusion. Despite the apparent complexity in the number of viral entry proteins, herpesvirus entry is fundamentally built around two core glycoprotein entities: the gHgL complex, which appears to act as an 'activator' of entry, and the gB protein, which is thought to act as the membrane 'fusogen'. Both are required for all herpesvirus fusion and entry. In many herpesviruses, gHgL either binds host receptors directly or assembles into larger complexes with additional viral proteins that bind host receptors, conferring specificity to the cells that are targeted for infection. These gHgL entry complexes (ECs) are centrally important to activating gB-mediated membrane fusion and establishing viral tropism, forming membrane bridging intermediates before gB triggering. Here we review recent structural and functional studies of Epstein-Barr virus (EBV) and Cytomegalovirus (CMV) gHgL complexes that provide a framework for understanding the role of gHgL in herpesvirus entry. Furthermore, a recently determined EM model of Herpes Simplex virus (HSV) gB embedded in exosomes highlights how gB conformational changes may promote viral and cellular membrane fusion.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28538165     DOI: 10.1016/j.coviro.2017.04.006

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  45 in total

1.  Using Split Luciferase Assay and anti-HSV Glycoprotein Monoclonal Antibodies to Predict a Functional Binding Site Between gD and gH/gL.

Authors:  Doina Atanasiu; Wan Ting Saw; Tina M Cairns; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

2.  The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes.

Authors:  Jing Liu; Ted S Jardetzky; Andrea L Chin; David C Johnson; Adam L Vanarsdall
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

Review 3.  Chemokines encoded by herpesviruses.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Leukoc Biol       Date:  2017-08-28       Impact factor: 4.962

4.  Humanization of Murine Neutralizing Antibodies against Human Herpesvirus 6B.

Authors:  Bochao Wang; Mitsuhiro Nishimura; Yuji Maekawa; Toshiya Kotari; Toshiomi Okuno; Yasuko Mori
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

5.  Endocytic Internalization of Herpes Simplex Virus 1 in Human Keratinocytes at Low Temperature.

Authors:  Nydia De La Cruz; Dagmar Knebel-Mörsdorf
Journal:  J Virol       Date:  2020-11-25       Impact factor: 5.103

6.  Structure-Function Dissection of Pseudorabies Virus Glycoprotein B Fusion Loops.

Authors:  Melina Vallbracht; Delphine Brun; Matteo Tassinari; Marie-Christine Vaney; Gérard Pehau-Arnaudet; Pablo Guardado-Calvo; Ahmed Haouz; Barbara G Klupp; Thomas C Mettenleiter; Felix A Rey; Marija Backovic
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

7.  Differential CircRNA Expression Profiles in PK-15 Cells Infected with Pseudorabies Virus Type II.

Authors:  Haimin Li; Wen Tang; Yulan Jin; Weiren Dong; Yan Yan; Jiyong Zhou
Journal:  Virol Sin       Date:  2020-07-02       Impact factor: 4.327

8.  Restriction of Human Cytomegalovirus Infection by Galectin-9.

Authors:  Allison Abendroth; Brian P McSharry; Barry Slobedman; Emily A Machala; Selmir Avdic; Lauren Stern; Dirk M Zajonc; Chris A Benedict; Emily Blyth; David J Gottlieb
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

9.  Exploiting 2A peptides to elicit potent neutralizing antibodies by a multi-subunit herpesvirus glycoprotein complex.

Authors:  Felix Wussow; Flavia Chiuppesi; Zhuo Meng; Joy Martinez; Jenny Nguyen; Peter A Barry; Don J Diamond
Journal:  J Virol Methods       Date:  2017-10-06       Impact factor: 2.014

Review 10.  The Viral Capsid: A Master Key to Access the Host Nucleus.

Authors:  Guillermo Blanco-Rodriguez; Francesca Di Nunzio
Journal:  Viruses       Date:  2021-06-20       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.